Lei Xu

Molecular Biology · Physiological Reviews · 2002–2011

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom Lei Xu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain

Who trusts Lei Xu overall

  1. Rakesh K. Jain
  2. Dai Fukumura

Papers from Lei Xu's perspective

Ordered by how strongly the researchers Lei Xu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Clinical translation of angiogenesis inhibitors (Nature Reviews. Cancer)
  3. Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
  4. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. (Cancer Cell)
  5. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis (Science)
  6. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. (Journal of Clinical Oncology)
  7. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
  8. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer (Nature reviews. Drug discovery)
  9. Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
  10. Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)

Their papers